How molecular signaling bias can lead to better drug design

About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
JD Supra

FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research

A recent article[1] authored by Haider J. Warraich, MD[2]; Troy Tazbaz[3]; and Robert M. Califf[4], MD in the Journal of the American Medical Association, reviews the history of artificial ...